The Board, inter alia, considered and approved the Launch of Aayush Labs: Redefining Preventive Healthcare Through Digital Diagnostics. A copy of the press release in this regard is enclosed ....
Price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Awaiting price reaction for this filing.
Aayush Wellness Ltd's board has approved the launch of 'Aayush Labs' (www.aayushlabs.com), a new digital diagnostics platform offering online test booking, home sample collection, digital report delivery and teleconsultations. The platform will run on an asset-light model supported by a central lab for quality assurance. The company is tapping into India's diagnostics market, which it cites as worth ₹1.54 trillion in FY2024 and projected to nearly double to ₹2.98 trillion by FY2030 at an 11.7% CAGR. This is a diversification move from the company's existing nutraceuticals, wellness and personal care business, aimed at building a vertically integrated preventive healthcare ecosystem. The company expects cross-selling opportunities with its existing wellness products and improved revenue visibility.
The launch opens a new high-growth revenue stream for Aayush Wellness, which could support long-term earnings and valuation expansion, though near-term impact on financials is unclear as no revenue guidance or investment numbers were disclosed. Shareholders should watch for traction metrics from the new platform in coming quarters.